RMMs In-Depth Focus
Posted: 13 December 2016 | European Pharmaceutical Review | 1 comment
In this RMMs In-Depth Focus: the role of statistical analysis in validating rapid microbiological methods; considerations when using RMMs for use in pharmaceutical microbiology; & RMMs roundtable…
- The role of statistical analysis in validating rapid microbiological methods
Michael J. Miller, PhD, Microbiology Consultants, LLC and rapidmicromethods.com, E. R. van den Heuvel, PhD, Eindhoven University of Technology and David Roesti, PhD, Novartis Pharmaceuticals - Considerations when choosing RMMs for use in pharmaceutical microbiology
Jelena Novaković Jovanović, Belgrade University - RMMs Roundtable
With Jeremy Robertson, Sr Product Manager, Charles River Microbial Solutions and Dr Annett Kilic, Key Account Manager, Biopharm. Applications/Div. Diagnostics, Greiner Bio-One
This RMMs In-Depth Focus is restricted - login or subscribe free to access
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Issue
Related topics
Related organisations
Belgrade University, Charles River, Eindhoven University, Greiner Bio-One, Microbiology Consultants LLC, Novartis Pharma AG
We are developing microwave sensors for contactless Monitoring microbial fermentation processes.
So we are also interested for statistically validations of or devices.